Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants

10Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

As a result of the COVID-19 pandemic, whether and when the world can reach herd immunity and return to normal life and a strategy for accelerating vaccination programmes constitute major concerns. We employed Metropolis-Hastings sampling and an epidemic model to design experiments based on the current vaccinations administered and a more equitable vaccine allocation scenario. The results show that most high-income countries can reach herd immunity in less than 1 year, whereas low-income countries should reach this state after more than 3 years. With a more equitable vaccine allocation strategy, global herd immunity can be reached in 2021. However, the spread of SARS-CoV-2 variants means that an additional 83 days will be needed to reach global herd immunity and that the number of cumulative cases will increase by 113.37% in 2021. With the more equitable vaccine allocation scenario, the number of cumulative cases will increase by only 5.70% without additional vaccine doses. As SARS-CoV-2 variants arise, herd immunity could be delayed to the point that a return to normal life is theoretically impossible in 2021. Nevertheless, a more equitable global vaccine allocation strategy, such as providing rapid vaccine assistance to low-income countries/regions, can improve the prevention of COVID-19 infection even though the virus could mutate.

Cite

CITATION STYLE

APA

Liu, F., Zhao, Z., Ma, C., Nie, X., Wu, A., & Li, X. (2022). Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants. Epidemiology and Infection, 150. https://doi.org/10.1017/S0950268822000139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free